The VivO2
Biosensor PLATFORM Technology Solution

In 2018 an idea was born to help save the lives of mothers and babies.  In just a few short years, through the labor of love, time, and dedication Prenatal Hope has grown into both a company and a MISSION.  

Our Mission is simple; to save the lives of babies and mothers using biomedical technology.  The United States alone, with all the advancements in the medical field, is still one of "the costliest and most dangerous place in the developed world to give birth" (NY Times, 2018)  The amount of unneccesary C-Sections are occurring at a staggering rate.  The subjective data that drives doctors to perform these c-sections is often grossly misrepresented.  
 

Within the United States alone there are approximately 43,000 OB-GYNS operating in over 6000 hospitals.  On average, each OB will perform 100 childbirth deliveries a year; 33% of those being c-sections.  Of those C-sections, 1/3 that are performed are suspect for fetal acidosis.  That equates to over 400,000 C-sections performed at a cost of roughly $32 BILLION spent nationally just on an assumption. The effects of an unnecessary c-section far outweigh the higher costs associated with them.  C-sections can lead to complications to the mother such as bleeding and infections.  They often result in a difficult recovery and longer hospital stays.  They can also lead to breathing difficulties for babies.     

​

The global market is certainly the largest opportunity for Prenatal Hope with an emphasis on midwives and independent birthing centers.  Unlike the U.S., most births around the world happen outside of hospitals where midwives face much less regulatory oversight; this often entails much more as litigation as well.  The most target-rich environment is in Europe where 75% of all births are performed by midwives.  Prenatal Hope is aligned with a global distributor of medical devices to expedite sales to foreign markets.  

​